Literature DB >> 21762823

HIV immune evasion disruption of antigen presentation by the HIV Nef protein.

Elizabeth R Wonderlich1, Jolie A Leonard, Kathleen L Collins.   

Abstract

The Human Immunodeficiency Virus (HIV) Nef protein is necessary for high viral loads and for timely progression to AIDS. Nef plays a number of roles, but its effect on antigen presentation and immune evasion are among the best characterized. Cytotoxic T lymphocytes (CTLs) recognize and lyse virally infected cells by detecting viral antigens in complex with host major histocompatibility complex class I (MHC-I) molecules on the infected cell surface. The HIV Nef protein disrupts antigen presentation at the cell surface by interfering with the normal trafficking pathway of MHC-I and thus reduces CTL recognition and lysis of infected cells. The molecular mechanism by which Nef causes MHC-I downmodulation is becoming more clear, but some questions remain. A better understanding of how Nef disrupts antigen presentation may lead to the development of drugs that enhance the ability of the anti-HIV CTLs to control HIV disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762823      PMCID: PMC3782996          DOI: 10.1016/B978-0-12-385987-7.00005-1

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN: 0065-3527            Impact factor:   9.937


  113 in total

1.  Two distinct members of the ADP-ribosylation factor family of GTP-binding proteins regulate cell-free intra-Golgi transport.

Authors:  T C Taylor; R A Kahn; P Melançon
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

2.  ADP-ribosylation factor, a small GTP-binding protein, is required for binding of the coatomer protein beta-COP to Golgi membranes.

Authors:  J G Donaldson; D Cassel; R A Kahn; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

3.  Coated vesicle assembly in the Golgi requires only coatomer and ARF proteins from the cytosol.

Authors:  L Orcl; D J Palmer; M Amherdt; J E Rothman
Journal:  Nature       Date:  1993-08-19       Impact factor: 49.962

4.  The amino terminus of ADP-ribosylation factor (ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of protein transport.

Authors:  R A Kahn; P Randazzo; T Serafini; O Weiss; C Rulka; J Clark; M Amherdt; P Roller; L Orci; J E Rothman
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

5.  ADP-ribosylation factor is required for vesicular trafficking between the endoplasmic reticulum and the cis-Golgi compartment.

Authors:  W E Balch; R A Kahn; R Schwaninger
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

6.  Long-term symptomless HIV-1 infection in recipients of blood products from a single donor.

Authors:  J Learmont; B Tindall; L Evans; A Cunningham; P Cunningham; J Wells; R Penny; J Kaldor; D A Cooper
Journal:  Lancet       Date:  1992-10-10       Impact factor: 79.321

7.  Activation of protein kinase C accelerates internalization of transferrin receptor but not of major histocompatibility complex class I, independent of their phosphorylation status.

Authors:  T Eichholtz; P Vossebeld; M van Overveld; H Ploegh
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

8.  Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF.

Authors:  J B Helms; J E Rothman
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

9.  Binding of coatomer to Golgi membranes requires ADP-ribosylation factor.

Authors:  D J Palmer; J B Helms; C J Beckers; L Orci; J E Rothman
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

10.  Differences in the endosomal distributions of the two mannose 6-phosphate receptors.

Authors:  J Klumperman; A Hille; T Veenendaal; V Oorschot; W Stoorvogel; K von Figura; H J Geuze
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

View more
  22 in total

1.  Down-modulation of CD8αβ is a fundamental activity of primate lentiviral Nef proteins.

Authors:  Anke Heigele; Michael Schindler; Clement W Gnanadurai; Jolie A Leonard; Kathleen L Collins; Frank Kirchhoff
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins.

Authors:  Claudia Haller; Birthe Müller; Joëlle V Fritz; Miguel Lamas-Murua; Bettina Stolp; François M Pujol; Oliver T Keppler; Oliver T Fackler
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 3.  Role of myeloid cells in HIV-1-host interplay.

Authors:  Mario Stevenson
Journal:  J Neurovirol       Date:  2014-09-19       Impact factor: 2.643

Review 4.  Chimeric antigen receptor engineered stem cells: a novel HIV therapy.

Authors:  Anjie Zhen; Mayra A Carrillo; Scott G Kitchen
Journal:  Immunotherapy       Date:  2017-03       Impact factor: 4.196

5.  Lentiviral Nef proteins manipulate T cells in a subset-specific manner.

Authors:  Hangxing Yu; Mohammad Khalid; Anke Heigele; Jan Schmökel; Shariq M Usmani; Johannes van der Merwe; Jan Münch; Guido Silvestri; Frank Kirchhoff
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 6.  Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infection.

Authors:  Barna Dey; Edward A Berger
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

7.  Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Authors:  Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

8.  MicroRNAs and exosomes: key players in HIV pathogenesis.

Authors:  J Sadri Nahand; F Bokharaei-Salim; M Karimzadeh; M Moghoofei; S Karampoor; H R Mirzaei; A Tabibzadeh; A Jafari; A Ghaderi; Z Asemi; H Mirzaei; M R Hamblin
Journal:  HIV Med       Date:  2019-11-22       Impact factor: 3.180

Review 9.  Viral disruption of the blood-brain barrier.

Authors:  Katherine R Spindler; Tien-Huei Hsu
Journal:  Trends Microbiol       Date:  2012-05-06       Impact factor: 17.079

10.  HIV-1 Nef and T-cell activation: a history of contradictions.

Authors:  Tristan J Markle; Mwimanzi Philip; Mark A Brockman
Journal:  Future Virol       Date:  2013-04-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.